Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ultra-long-acting removable drug delivery system for HIV treatment and prevention.
Kovarova M, Benhabbour SR, Massud I, Spagnuolo RA, Skinner B, Baker CE, Sykes C, Mollan KR, Kashuba ADM, García-Lerma JG, Mumper RJ, Garcia JV. Kovarova M, et al. Among authors: massud i. Nat Commun. 2018 Oct 8;9(1):4156. doi: 10.1038/s41467-018-06490-w. Nat Commun. 2018. PMID: 30297889 Free PMC article.
Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting.
Romano JW, Baum MM, Demkovich ZR, Diana F, Dobard C, Feldman PL, Garcia-Lerma JG, Grattoni A, Gunawardana M, Ho DK, Hope TJ, Massud I, Milad M, Moss JA, Pons-Faudoa FP, Roller S, van der Straten A, Srinivasan S, Veazey RS, Zane D. Romano JW, et al. Among authors: massud i. AIDS Res Hum Retroviruses. 2021 Jun;37(6):409-420. doi: 10.1089/AID.2021.0028. AIDS Res Hum Retroviruses. 2021. PMID: 33913760 Free PMC article. Review.
Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.
Massud I, Cong ME, Ruone S, Holder A, Dinh C, Nishiura K, Khalil G, Pan Y, Lipscomb J, Johnson R, Deyounks F, Rooney JF, Babusis D, Park Y, McCallister S, Callebaut C, Heneine W, García-Lerma JG. Massud I, et al. J Infect Dis. 2019 Oct 22;220(11):1826-1833. doi: 10.1093/infdis/jiz383. J Infect Dis. 2019. PMID: 31362305
Proinflammatory oscillations over the menstrual cycle drives bystander CD4 T cell recruitment and SHIV susceptibility from vaginal challenge.
Swaims-Kohlmeier A, Sheth AN, Brody J, Hardnett FP, Sharma S, Bonning EW, Ofotokun I, Massud I, García-Lerma JG. Swaims-Kohlmeier A, et al. Among authors: massud i. EBioMedicine. 2021 Jul;69:103472. doi: 10.1016/j.ebiom.2021.103472. Epub 2021 Jul 3. EBioMedicine. 2021. PMID: 34229275 Free PMC article. Clinical Trial.
Comparative Pharmacokinetics and Local Tolerance of Tenofovir Alafenamide (TAF) From Subcutaneous Implant in Rabbits, Dogs, and Macaques.
Gatto GJ, Krovi A, Li L, Massud I, Holder A, Gary J, Mills P, Mitchell J, Luecke E, Demkovich ZR, Heneine W, García-Lerma JG, Marzinke MA, Brand RM, Dobard CW, Johnson LM, Van Der Straten A. Gatto GJ, et al. Among authors: massud i. Front Pharmacol. 2022 Jul 19;13:923954. doi: 10.3389/fphar.2022.923954. eCollection 2022. Front Pharmacol. 2022. PMID: 35928266 Free PMC article.
Safety and efficacy of a biodegradable implant releasing tenofovir alafenamide for vaginal protection in a macaque model.
Massud I, Krovi A, Nishiura K, Ruone S, Li L, Holder A, Gary J, Mills P, Mitchell J, Khalil G, Pan Y, Luecke E, Gatto G, Heneine W, García-Lerma JG, Johnson L, van der Straten A, Dobard C. Massud I, et al. J Antimicrob Chemother. 2022 Oct 28;77(11):2964-2971. doi: 10.1093/jac/dkac252. J Antimicrob Chemother. 2022. PMID: 35913838 Free PMC article.
23 results